Nevro EPS - Earnings per Share 2013-2024 | NVRO
Nevro eps - earnings per share from 2013 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Nevro Annual EPS | |
|---|---|
| 2023 | $-2.56 |
| 2022 | $0.08 |
| 2021 | $-3.77 |
| 2020 | $-2.47 |
| 2019 | $-3.37 |
| 2018 | $-1.64 |
| 2017 | $-1.25 |
| 2016 | $-1.12 |
| 2015 | $-2.54 |
| 2014 | $-6.94 |
| 2013 | $-29.84 |
| 2012 | $-38.59 |
| Nevro Quarterly EPS | |
|---|---|
| 2024-09-30 | $-0.41 |
| 2024-06-30 | $-0.53 |
| 2024-03-31 | $-0.70 |
| 2023-12-31 | $-0.24 |
| 2023-09-30 | $-0.65 |
| 2023-06-30 | $-0.69 |
| 2023-03-31 | $-0.98 |
| 2022-12-31 | $-0.45 |
| 2022-09-30 | $2.22 |
| 2022-06-30 | $-0.71 |
| 2022-03-31 | $-0.98 |
| 2021-12-31 | $-0.86 |
| 2021-09-30 | $-1.44 |
| 2021-06-30 | $-0.62 |
| 2021-03-31 | $-0.85 |
| 2020-12-31 | $-0.19 |
| 2020-09-30 | $-0.29 |
| 2020-06-30 | $-1.21 |
| 2020-03-31 | $-0.78 |
| 2019-12-31 | $-0.43 |
| 2019-09-30 | $-0.58 |
| 2019-06-30 | $-0.91 |
| 2019-03-31 | $-1.45 |
| 2018-12-31 | $-0.33 |
| 2018-09-30 | $-0.37 |
| 2018-06-30 | $-0.35 |
| 2018-03-31 | $-0.59 |
| 2017-12-31 | $-0.14 |
| 2017-09-30 | $-0.21 |
| 2017-06-30 | $-0.40 |
| 2017-03-31 | $-0.50 |
| 2016-12-31 | $-0.34 |
| 2016-09-30 | $-0.14 |
| 2016-06-30 | $-0.31 |
| 2016-03-31 | $-0.33 |
| 2015-12-31 | $-0.50 |
| 2015-09-30 | $-0.70 |
| 2015-06-30 | $-0.77 |
| 2015-03-31 | $-0.57 |
| 2014-12-31 | $12.20 |
| 2014-09-30 | $-5.96 |
| 2014-06-30 | $-6.58 |
| 2014-03-31 | $-6.60 |
| 2013-12-31 | $0.00 |
| 2013-09-30 | $-5.54 |
| 2012-12-31 | $0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.153B | $0.425B |
| Nevro Corp. is a medical device company which engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain, primarily in the leg. The company is known for developing and commercializing the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. Additionally, the company's HF10 therapy provides long-lasting relief from chronic back and leg pain. Nevro's flagship Senza SCS system has been consistently driving the top line. Since its commercial launch in the United States, the system raked in significant revenues. These apart, Senza is commercially available in Europe since 2010 and in Australia since 2011. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $201.535B | 24.59 |
| Intuitive Surgical (ISRG) | United States | $192.187B | 100.48 |
| Edwards Lifesciences (EW) | United States | $43.244B | 27.46 |
| Alcon (ALC) | Switzerland | $41.516B | 27.78 |
| IQVIA Holdings (IQV) | United States | $36.129B | 19.91 |
| IDEXX Laboratories (IDXX) | United States | $35.383B | 41.67 |
| DexCom (DXCM) | United States | $30.150B | 45.41 |
| Waters (WAT) | United States | $22.460B | 33.21 |
| STERIS (STE) | Ireland | $21.145B | 24.34 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.656B | 0.00 |
| Hologic (HOLX) | United States | $16.714B | 18.05 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.878B | 14.25 |
| Sysmex ADR (SSMXY) | Japan | $11.893B | 37.30 |
| Globus Medical (GMED) | United States | $11.223B | 28.42 |
| Masimo (MASI) | United States | $9.431B | 45.63 |
| Penumbra (PEN) | United States | $9.424B | 92.31 |
| Teleflex (TFX) | United States | $8.366B | 13.34 |
| Glaukos (GKOS) | United States | $7.660B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.657B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.653B | 26.37 |
| Veracyte (VCYT) | United States | $3.350B | 100.51 |
| Inari Medical (NARI) | United States | $3.254B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.797B | 16.14 |
| Nihon Kohden (NHNKY) | Japan | $2.380B | 18.08 |
| Elekta AB (EKTAY) | Sweden | $2.206B | 19.83 |
| TransMedics (TMDX) | United States | $2.157B | 68.36 |
| Tandem Diabetes Care (TNDM) | United States | $2.145B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.854B | 9.69 |
| RxSight (RXST) | United States | $1.503B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.364B | 0.00 |
| Artivion (AORT) | United States | $1.213B | 80.36 |
| Pulse Biosciences (PLSE) | United States | $1.086B | 0.00 |
| OPKO Health (OPK) | United States | $1.085B | 0.00 |
| Paragon 28 (FNA) | United States | $0.872B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.826B | 14.04 |
| Mesa Laboratories (MLAB) | United States | $0.693B | 16.33 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.686B | 0.00 |
| IRadimed (IRMD) | United States | $0.667B | 36.05 |
| AxoGen (AXGN) | United States | $0.623B | 0.00 |
| SiBone (SIBN) | United States | $0.563B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.557B | 32.77 |
| Pacific Biosciences Of California (PACB) | United States | $0.537B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.536B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.467B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.430B | 23.27 |
| ClearPoint Neuro (CLPT) | United States | $0.423B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.387B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.366B | 0.00 |
| NeuroPace (NPCE) | United States | $0.329B | 0.00 |
| CVRx (CVRX) | United States | $0.311B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.215B | 0.00 |
| Inogen (INGN) | United States | $0.213B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.197B | 0.00 |
| Accuray (ARAY) | United States | $0.193B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.182B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.141B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.134B | 14.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.099B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.091B | 0.00 |
| LENSAR (LNSR) | United States | $0.088B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.084B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.082B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.079B | 0.00 |
| InspireMD (NSPR) | Israel | $0.077B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| 908 Devices (MASS) | United States | $0.072B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.064B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.050B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.047B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.043B | 0.00 |
| Envoy Medical (COCH) | United States | $0.040B | 0.00 |
| Neuronetics (STIM) | United States | $0.034B | 0.00 |
| Spectral AI (MDAI) | United States | $0.033B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| NexGel (NXGL) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.029B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.025B | 0.00 |
| DarioHealth (DRIO) | United States | $0.025B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.011B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.010B | 0.00 | |
| PAVmed (PAVM) | United States | $0.008B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |